# Exploratory Study on Predicting CIDP Patients' Decline During IV Immunoglobulin Treatment Adaptation Feasibility.

> **NCT06183645** · — · RECRUITING · sponsor: **Centre Hospitalier Universitaire de Liege** · enrollment: 40 (estimated)

## Conditions studied

- Chronic Inflammatory Demyelinating Polyneuropathy

## Interventions

- **DEVICE:** Actimyo

## Key facts

- **NCT ID:** NCT06183645
- **Lead sponsor:** Centre Hospitalier Universitaire de Liege
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2023-08-28
- **Primary completion:** 2028-01
- **Final completion:** 2028-01
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2025-02-12

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06183645

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06183645, "Exploratory Study on Predicting CIDP Patients' Decline During IV Immunoglobulin Treatment Adaptation Feasibility.". Retrieved via AI Analytics 2026-06-14 from https://api.ai-analytics.org/clinical/NCT06183645. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*